Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Roby Thomas"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/6b89cf8a1af94b139cf2d923e283d6f2
Publikováno v:
PLoS Computational Biology, Vol 15, Iss 2, p e1006730 (2019)
Prediction of response to specific cancer treatments is complicated by significant heterogeneity between tumors in terms of mutational profiles, gene expression, and clinical measures. Here we focus on the response of Estrogen Receptor (ER)+ post-men
Externí odkaz:
https://doaj.org/article/09759d561955487aafc952119d4b6105
Autor:
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree, Monica Malhotra, Roby Thomas, Dennis Hsu, Anwaar Saeed
Publikováno v:
JCO Oncology Practice. 19:251-259
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment paradigm of mismatch repair–deficient/microsatellite instability-high (MMMR-D/MSI-H) colorectal cancer (CRC). Unique molecular features of MMR-D/MSI-H CRC with frameshift alterat
Autor:
Ryan Augustin, Andrew Poklepovic, Xin Gao, William Gooding, Sarah Brodeur, Julie Urban, Amy Rose, Amy Goodman, Darcy Ploucha, Roby Thomas, Dan Zandberg, John Kirkwood, Yana Najjar, Diwakar Davar, Liza Villaruz, Jan Beumer, Riyue Bao, Jason Luke
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Mark Stein, Oscar Goodman, Tanya Dorff, Vivek Narayan, Jose Avitia, Rana McKay, Luke Nordquist, Matthew Rettig, Michael Schweizer, Roby Thomas, Michael Silverman, Li Yao, Raphael Clynes, Jolene Shorr
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Abigail Wald, James Pingpank, Melanie Ongchin, Lauren Hall, Heather Jones, Shannon Altpeter, Michele Liebdzinski, Ahmed Hamed, Joshua Derby, Marina Nikiforova, Phoenix Bell, Alessandro Paniccia, Amer Zureikat, Vikram Gorantla, John Rhee, Roby Thomas, David Bartlett, Katelyn Smith, Patrick Henn, Brian Theisen, Susan Shyu, Akram Shalaby, Haroon Choudry, Aatur Singhi
Appendiceal mucinous neoplasms (AMNs) with disseminated disease are a heterogeneous group of tumors with variable clinicopathologic behavior. Despite the development of prognostic systems, objective biomarkers are needed to accurately stratify patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43031ed9e133682586dcf09c44c9251b
https://doi.org/10.21203/rs.3.rs-1821239/v1
https://doi.org/10.21203/rs.3.rs-1821239/v1
Autor:
Hossein Asghari, Ehsan Haghshenas, Roby Thomas, Eric Schultz, Rob Patro, Stan Skrzypczak, Carl Kingsford
Publikováno v:
Cancer Research. 83:1400-1400
We introduce a new algorithm employing bulk RNA-seq to identify a robust set of genes associated with response, resulting in one of the first multi-gene expression biomarkers for efficacy of FFX in PDAC. Ocean Genomics TxomeAI® processed 103 pre-tre
Autor:
Swati, Satturwar, Anil V, Parwani, Roby, Thomas, Sheldon, Bastacky, Rajiv, Dhir, Gabriela M, Quiroga-Garza
Publikováno v:
Pathology - Research and Practice. 239:154164
Osteoclast-type giant cell-rich carcinomas (OGCRCs) of urinary bladder are extremely rare, aggressive tumors that are often diagnosed as undifferentiated carcinomas. The morphology overlaps with other giant cell-rich benign and malignant bladder lesi
Autor:
Roby, Thomas W.
Publikováno v:
Curriculum Inquiry, 1978 Jul 01. 8(2), 95-117.
Externí odkaz:
https://www.jstor.org/stable/1179673
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.